Oriola Oyj (LON:0NES)

Market Cap	168.35M
Revenue (ttm)	1.39B
Net Income (ttm)	-16.62M
Shares Out	n/a
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	0.06 (5.46%)
Ex-Dividend Date	Apr 3, 2025

Volume	10,010
Average Volume	17,363
Open	1.092
Previous Close	1.081
Day's Range	1.084 - 1.094
52-Week Range	0.894 - 1.534
Beta	0.59
RSI	56.88
Earnings Date	Apr 29, 2025

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1907
• Employees: 934
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NES

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.

Financial numbers in EUR